Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001178913-25-002400
Filing Date
2025-07-17
Accepted
2025-07-17 11:57:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7210
  Complete submission text file 0001178913-25-002400.txt   9179
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV Israel
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV Israel 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-55457 | Film No.: 251129595
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address MENORA HOUSE 23 JABOTINSKY ST. RAMAT GAN L3 5251102
Business Address MENORA HOUSE 23 JABOTINSKY ST. RAMAT GAN L3 5251102 972-3-710-7864
MENORA MIVTACHIM HOLDINGS LTD. (Filed by) CIK: 0001351917 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SCHEDULE 13G